FDA Approves Bayer's Novel Stroke-Prevention Drug, First in New Class

Source Summary

The U.S. Food and Drug Administration has approved a Bayer drug designed to reduce stroke recurrence. The medication is the first in a novel class of drugs engineered to prevent blood clots without elevating bleeding risk.

Why it matters

This approval represents a therapeutic advance in stroke prevention, offering a mechanism that addresses a major clinical challenge of balancing clot prevention with bleeding safety.